Background:
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disease and a drug which targets a single protein will not provide a cure for the disease. Currently available drugs for AD are all palliative rather than curative. FDA approved only five drugs for the treatment of AD, which includes tacrine, donepezil, galantamine, rivastigmine, and memantine. Tacrine discontinued due to its hepatotoxicity. The lack of therapeutic effectiveness of the single-target drugs and multifactorial etiology of AD leads to the design of multitarget directed ligands for AD.
Objective:
The researchers in this field are constantly putting effort for the development of a drug for the exact cure of this disease by exploring the different biological targets associated with AD. The present review comprises various multitarget approaches and tools used for finding out a lead compound or a new drug, which will give a cure for AD.
Methods:
We have scrutinized and reviewed 75 research articles published in various peer reviewed journals in the last two decades in the field of multi target directed ligand approaches for the discovery of a new therapeutic agent for AD.
Results:
The review highlights the recent advances in the field of AD research and showed that still the battle for the discovery of an effective drug for AD is in process and AD still remains an incurable disease for which treatment is just palliative.
Conclusion:
The review might be helpful for researchers working on multi target directed ligands against AD.
Sodium hydroxide on treatment with bromine and pthalamide followed by reaction with hydrochloric acid gave anthranillic acid 1. Compound 1 on further reaction with sodium hydroxide and benzoyl chloride yields 2-phenyl benzoxizanone 2, Compound 2 further reactions with substituted anilines yielded the corresponding 2a to 2f respectively. All the synthesized compounds have been screened for their antioxidant and anticancer activity.
Pharmaceutical analysis plays an indispensable role in various stages of drug pipeline including drug development, fabrication of formulation, stability studies and quality control. It is also used for characterizing the composition of different dosage forms in quantitative and qualitative ways. Comprehensive literature survey forms the foundation stone for the focused analysis of research activity. Irbesartan is a hypertension antagonist chiefly employed in the treatment of high blood pressure which is an Angiotensin II Receptor blocker. The multiple mixtures of various antihypertensive medicaments raise challenges in the method development and validation. A genuine venture is undertaken to compile the literatures related to the antihypertensive drug Irbesartan published in various peer reviewed journals. HPLC and UV spectrophotometry are the most preferred analytical techniques when compared to other methods. This present review provides an in-depth assortment of various analytical techniques published for Irbesartan and its combinations, which will help the researchers in their future endeavors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.